Tenax Therapeutics, Inc.
TENX
$9.01
-$0.06-0.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -197.55% | -150.42% | -139.64% | -128.27% | -107.01% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -84.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6,908.73% | 3,905.39% | 1,824.38% | 431.28% | -15.45% |
| Change in Net Operating Assets | 10.33% | 118.27% | 404.54% | 3.78% | 477.46% |
| Cash from Operations | -107.98% | -73.26% | -77.76% | -150.86% | -94.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -92.86% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -97.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.99% | 50.82% | 31.34% | 19.71% | -690.63% |
| Issuance of Common Stock | 101.70% | 245,100.00% | 3,037.09% | -87.37% | -87.37% |
| Repurchase of Common Stock | -606.21% | -592.43% | -592.48% | -592.48% | -72.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.63% | 851.65% | 851.70% | 1,300.65% | 1,321.05% |
| Cash from Financing | -72.93% | 1,457.45% | 1,444.83% | 636.02% | 624.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.79% | 2,496.02% | 5,399.44% | 1,009.27% | 1,088.44% |